Form D — Immuno Cancer Biotherapeutics, Inc.
0002158173-26-000001 · filed Oct 15, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- —
- Total sold
- $75,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Immuno Cancer Biotherapeutics, Inc.
- CIK
- 2158173
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 48351 277TH ST
CANTON, SD 57013-5507 - Phone
- 6053107663
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James Robl · Executive OfficerCANTON, SD Find on LinkedIn ↗
-
Stephen Collins · DirectorLAKE FOREST, IL Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗